Osaic Holdings
PRME icon

Osaic Holdings’s Prime Medicine PRME Stock Holding History

Osaic Holdings’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.7K Buy
9,398
+5,301
+129% +$17.6K ﹤0.01% 5745
2026
Q1 		$14.3K Sell
4,097
-4,331
-51% -$16.5K ﹤0.01% 6078
2025
Q4 		$29.2K Buy
8,428
+1,478
+21% +$6.57K ﹤0.01% 5603
2025
Q3 		$37.4K Buy
6,950
+6,822
+5,330% +$27.7K ﹤0.01% 5501
2025
Q2 		$315 Sell
128
-36
-22% -$55 ﹤0.01% 7444
2025
Q1 		$324 Sell
164
-224
-58% -$571 ﹤0.01% 7088
2024
Q4 		$1.13K Sell
388
-9,513
-96% -$33.4K ﹤0.01% 6806
2024
Q3 		$38.3K Sell
9,901
-800
-7% -$3.71K ﹤0.01% 4933
2024
Q2 		$55K Sell
10,701
-908
-8% -$5.5K ﹤0.01% 4607
2024
Q1 		$81.3K Sell
11,609
-1,961
-14% -$14.9K ﹤0.01% 4389
2023
Q4 		$120K Buy
13,570
+5,608
+70% +$43.2K ﹤0.01% 4300
2023
Q3 		$75.9K Buy
7,962
+1,559
+24% +$20.3K ﹤0.01% 4707
2023
Q2 		$93.8K Sell
6,403
-28
-0.4% -$391 ﹤0.01% 4487
2023
Q1 		$79.1K Buy
6,431
+402
+7% +$6.55K ﹤0.01% 4629
2022
Q4 		$112K Buy
+6,029
New +$109K ﹤0.01% 4335

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Osaic Holdings's PRME Position: Q2 2026 in Review

Osaic Holdings increased its Prime Medicine (PRME) stake by 129% in Q2 2026, buying an estimated $17.6K and bringing the position to 9,398 shares worth $34.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5745.

Osaic Holdings first reported a position in PRME in Q4 2022 and has held it in 15 quarters since. The position peaked at $120K in Q4 2023. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Osaic Holdings held 9,398 shares of Prime Medicine worth $34.7K as of Q2 2026.
  • Osaic Holdings bought 5,301 Prime Medicine shares in Q2 2026, an estimated $17.6K.
  • Prime Medicine made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5745 holding.
  • Osaic Holdings first reported a position in Prime Medicine in Q4 2022 and has held it in 15 quarters since.
  • Osaic Holdings's Prime Medicine position peaked at $120K in Q4 2023.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.